flow trial semaglutide kidney outcomes hazard ratio 0.76 Media Centre flow semaglutide Results from this

Gut-health supplements typically require consistent use over time before any effects may be noticed

Obesity, inflammation, and cancer

What the human evidence shows: weight, body composition, and performance Several randomized human trials and metaanalyses have reported modest but consistent reductions in body weight and fat mass with Lcarnitine supplementation

Resistance exercise training in individuals with and without cardiovascular disease: 2023 update: a scientific statement from the American heart association

In a study published this summer in JAMA Ophthalmology , people with Type 2 diabetes who took GLP-1s had double the risk of developing neovascular age-related macular degeneration than those who didnt